Chinese vaccines set to swarm developing world


Global recognition: Two Chinese vaccines are being used by many countries now – CoronaVac (left) and the WHO-listed Sinopharm vaccine (right).

With the world facing acute shortage in Covid-19 vaccines, WHO’s nod for global use of China’s Sinopharm vaccine provides a huge relief.

IN recent weeks, there has been an incessant flow of exciting news on Chinese vaccines that carries wide-ranging implications for China as well as vaccine-deprived developing countries.

On May 7, the World Health Organisation announced its approval for emergency use a Covid-19 vaccine from China’s government-owned drugmaker Sinopharm, greenlighting it to be rolled out globally.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Covid-19 vaccines , WHO , China , Sinopharm vaccine ,

Next In Columnists

Malaysia’s message at Apec
Cables and connections
Fighting the impulse buying lure
So much to do, with little time
Pet ownership must not burden neighbours
When knowledge has no heirs
Green wave has become a Malay tsunami
A cut above? Circumcision and cancer risk
Affordability, not culture wars
Can silat parry the puppeteer’s strings?

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read